Publication Addition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report). Kamal R, Pathak V, Kumari A, et al. The British journal of dermatology. 2016;
